iX Biopharma Ltd. announced Retirement of Mr. Low Weng Keong as Independent and Non-Executive Director. He retires from duties of an Independent and Non-Executive Director; Chairperson of the Audit Committee; a member of Nominating Committee, Remuneration Committee and Risk Management Committee. Other Director Ships Past: Confederation of Asian and Pacific Accountants Limited - UOL Group Limited - Riverstone Holdings Limited - NTUC Education and Training Fund (as member of Board of Trustees).

Other Director Ships Present: Haw Par Corporation Limited - Aquarius Investment Advisors Pte Ltd. - Singapore Institute of Accredited Tax Practitioners Limited (Singapore) Singapore's Tax Accreditation Body. In accordance with Regulation 85 of the Company's Constitution, Mr. Low Weng Keong is one of the Directors to retire by rotation at the Company's forthcoming Annual General Meeting. However, he will not be offering himself for the re-election and will retire as a Director of the Company on 14 October 2022, at the conclusion of the AGM, to facilitate Board renewal.

Based on its enquiries, the Company's Sponsor, UOB Kay Hian Private Limited, is satisfied that, save as disclosed in the announcement, there are no other material reasons for the retirement of Mr. Low Weng Keong as the Independent and Non-Executive Director of the company.